Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
Clinical trial NCT02581657 · COMPLETED
Trial details
- NCT number
- NCT02581657
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-11-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.